Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, November 29, 2023
Hovione, the specialist integrated CDMO, leader in spray drying and particle engineering, just announced an expansion of its nasal drug delivery capabilities with the addition of a family of innovative nasal powder delivery devices developed in ...
read more
Monday, November 27, 2023
Hovione, a leading integrated Contract Development and Manufacturing Organization (CDMO) specializing in spray drying and particle engineering, has officially acquired ExtremoChem Lda (ExtremoChem), an inventive startup focused on synthesizing, ...
read more
Thursday, September 08, 2022
Hovione has expanded its continuous manufacturing offering and services. A new state-of-the-art continuous manufacturing facility is now coming online at the Loures site in Portugal.
read more
Hovione recently held the official groundbreaking for the expansion of its New Jersey Facility in East Windsor, NJ.
read more
Hovione today announced the appointment of Dr. Filipe Gaspar as Vice President of its Research and Development organization. Dr. Gaspar will lead teams based in Lisbon and New Jersey that serve our clients’ drug development projects; he will also be...
read more
Wednesday, September 27, 2017
Hovione announced today the appointment of Frédéric Kahn as Vice President Marketing and Sales.
read more
Hovione today announced the appointment of Dr. Justin Hughey to lead the Particle Design sciences at our site in New Jersey. With over 30 publications, posters and book chapters Dr. Hughey is an acknowledged expert in the field of solubilization ...
read more
Friday, September 20, 2019
Hovione announced details of its planned Phase 3 development program for the treatment of moderate to severe inflammatory rosacea.
read more
Hovione will initiate recruitment for its Phase 1 clinical trial of HY02, a proprietary minocycline sterile ointment to treat a subset of ocular surface inflammation, generally manifesting on the inner edge of the eyelids, leading to eye irritation ...
read more
Hovione announced a new MG2 Tekna Precision Capsule filling unit is now online in its Portugal facilities.
read more
Wednesday, September 30, 2020
Hovione announced the signing of a partnership agreement with Ligand to ramp up the production output of Captisol.
read more
Hovione announced that Dr. Jean Luc Herbeaux has decided to step down from his role as Chief Executive Officer for personal reasons, effective as of May 21, 2026. To facilitate a smooth transition, Dr. Herbeaux will continue with the company until ...
read more
Hovione announced the appointment of Dr. Jean-Luc Herbeaux as Chief Operating Officer (COO), effective May 1st, 2020.
read more
Tuesday, February 22, 2022
Hovione a provider of spray drying and particle engineering, announced a strategic partnership with Zerion Pharma to market and commercialize Dispersome®, Zerion´s proprietary solubility enhancement technology platform.
read more
Hovione and Ripple Therapeutics have entered into a strategic partnership to expand the use of Ripple's Epidel® platform beyond ophthalmic applications.
read more